Piperacillin and Tazobactam
These highlights do not include all the information needed to use PIPERACILLIN AND TAZOBACTAM FOR INJECTION safely and effectively. See full prescribing information for PIPERACILLIN AND TAZOBACTAM FOR INJECTION. PIPERACILLIN and TAZOBACTAM for injection, for intravenous use Initial U.S. Approval: 1993
Approved
Approval ID
24d9b4f1-109c-4db4-8a99-03afff045b47
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 3, 2024
Manufacturers
FDA
Armas Pharmaceuticals Inc.
DUNS: 098405973
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Piperacillin and Tazobactam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72485-403
Application NumberANDA065458
Product Classification
M
Marketing Category
C73584
G
Generic Name
Piperacillin and Tazobactam
Product Specifications
Route of AdministrationPARENTERAL, INTRAVENOUS
Effective DateJanuary 3, 2024
FDA Product Classification
INGREDIENTS (2)
PIPERACILLIN SODIUMActive
Quantity: 3 g in 15 mL
Code: M98T69Q7HP
Classification: ACTIM
TAZOBACTAM SODIUMActive
Quantity: 0.375 g in 15 mL
Code: UXA545ABTT
Classification: ACTIM